Vincerx (VINCW) stock price, charts, trades & the US's most popular discussion forums. Minimum 15 minutes delayed. Vincerx Pharma Announces FDA Clearance of IND for Phase 1b Study of VIP152 in Chronic Lymphocytic Leukemia and Richter Syndrome PRESS … Stock analysis for Vincerx Pharma Inc (LSAC) including stock price, stock chart, company news, key statistics, fundamentals and company profile. The stock information is provided by a third party service, and Vincera Pharma, Inc. does not maintain or provide information directly to this service. stock was originally listed at a price of $10.25 in Mar 6, 2020. The Company focuses on the development and oncology knowledge to advance new therapies for the treatment of cancer. Get the latest Vincerx Pharma Inc (VINC) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions. Vincerx Pharma. Overview. If you had invested in Vincerx Pharma stock at $10.25, your return over the last 1 years would have been 85.95%, for an annualized return of 85.95%. A high-level overview of Vincerx Pharma, Inc. (VINC) stock. Vincerx Pharma, Inc. Common Stock (VINC) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. View the latest Vincerx Pharma Inc. (VINC) stock price, news, historical charts, analyst ratings and financial information from WSJ. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. Free forex prices, toplists, indices and lots more. Vincerx Pharma, Inc., formerly Vincera Pharma, Inc., is a clinical-stage life sciences company. Vincerx Pharma, Inc. (VINC) Stock Price: $24.63 USD -0.73 (-2.88%) Updated Mar 18, 2021 4:00 PM EDT - Market closed. Vincerx Pharma Stock Price Forecast, VINC stock price prediction. The stock information provided is for informational purposes only and is not intended for trading purposes. Stock Chart. Data Provided by Refinitiv.